|
1999/2000 Research Operating Funds |
| INVESTIGATORS | AGENCY | YEAR | AMOUNT |
| DESILETS VALERIE | FRSQ (co-investigator) | 1999-2000 | $ 15,000 |
| ELEANOR ELSTEIN | Parke-Davis Pharmaceuticals | $ 6,000 | |
| WILLIAM FOULKES | Canadian Breast Cancer Foundation (principal investigator) | $ 75,000 |
|
| US Army - principal investigator | 1998-2000 | $ 123,000 US/yr | |
| National Cancer Institute of Canada | 1999-2002 | $ 302,000 | |
| National Cancer Institute of Canada (co-investigator) PI: Parvis Ghadirian, PhD | 1999-2000 | $ 47,500 | |
| Cancer Research Society | 1999-2000 | $ 57,000 | |
| US Army | 1999-2002 | $ 287,000 | |
| CBCRI: Breast Cancer | 2000 | $ 38,120 | |
| National Institutes of Health | 1999-2001 | $ 347,230 US |
|
| National Cancer Institute of Canada Operating Grant | 1999-2000 | $ 10,000 |
|
| BRIAN GILFIX | Baxter ExtraMural Grant Program | 1998-1999 | $ 74,067 |
| Réseau CIDA et maladies infectieuses du FRSQ | 1998-1999 | $ 25,000 | |
| Fonds de la recherche en santé du Québec: Réseau de médécine génétique appliquée | 1998-1999 | $ 5,000 | |
| THOMAS HUDSON | Canada Foundation for Innovation and matching funds from Government of Quebec, Biochem Pharma, PE Applied Biosystems & Fisher Scientific (Group Grant) | 1999-2003 | $ 8,250,000 |
| Medical Research Council of Canada | 1999-2001 | $132,744/yr | |
| Medical Research Council of Canada - Clinical Scientist Award Phase II | 1996-1999 | $ 40,000/yr |
|
| Networks of Centres of Excellence - Phase III | 1998-2005 | ||
|
$ 95,563/yr | ||
|
$ 98,566/yr | ||
| Bristol-Myers Squibb, Millennium Pharmaceuticals Inc., Affymetrix | |||
| 1998-2000 | $ 512,000 US/yr | ||
| 1999-2000 | $ 500,000 US/yr |
||
| Medical Research Council of Canada: | |||
|
1999-2000 | $ 77,092 |
|
| 2000-2001 | $ 77,092 |
||
| Muscular Dystrophy Association of Canada: | 1998-2000 | $ 10,000/yr |
|
| National Institute of Health (NIH) | 1998-2000 | $ 2,607,695 US/yr |
|
| Office of Energy Research, United States | 1998-2000 | $ 5,458,417 US/yr | |
| Medical Research Council of Canada (Operating Grant) Operating Budget | 1999-2002 | $ 43,000/yr |
|
| Networks of Centres of Excellence-Phase I | |||
| 1999-2000 | $ 24,000/yr | ||
| (T. Hudson's allocation t.b.d.) | 2000-2003 | ||
| US Army | |||
| (T. Hudson's allocation expected) | 1999-2000 | $ 2,000 US | |
| (T. Hudson's allocation expected) | 2000-2001 | $ 2,000 US | |
| (T. Hudson's allocation expected) | 2001-2002 | $ 17,000 US | |
| KENNETH MORGAN | Networks of Centres of Excellence (co-investigator) | 1998-1999 | $ 161,925 |
| Medical Research Council of Canada (co-investigator) | 1998-1999 | $ 150,143 | |
| DAVID S. ROSENBLATT | Medical Research Council of Canada - Genetics Group | 1998-2001 | $ 91,426 |
| NIH Group Grant | 1998-2001 | $ 17,857US/yr | |
| GUY ROULEAU | Medical Research Council of Canada | 1999-2002 | $ 95,000 |
| Restless Legs Syndrome Foundation, Inc. | 1999-2000 | $ 35,000 US | |
| National Institute of Health | 1999-2002 | $ 166,000 US | |
| Heart and Stroke Foundation of Canada | 1999-2002 | $ 16,500 | |
| NCE - Genetic Diseases | 1998-2001 | $ 60,000 | |
| National Cancer Institutes of Canada | 1997-2000 | $ 122,765 | |
| Muscular Dystrophy Association | 1998-2001 | $ 125,000 US | |
| Muscular Dystrophy Association | 1998-2001 | $ 60,000 US | |
| PATRICIA TONIN | Cancer Research Society of Canada Inc. and Medical Research Council of Canada Scholarship | 1995-2000 | $ 50,000/yr |
| Montreal General Hospital Research Institute Fellowship | May
1, 1997 -April 10, 1999 |
$ 6,000/yr | |
| National Cancer Institute of Canada | July
1, 1998 - June 30, 1999 |
$ 47,841 | |
| Medical Research Council of Canada | 1998-1999 | $ 13,856 | |
| Canadian Breast Cancer Research Initiative | 1996-1999 | $ 97,000 | |
| 1998-2000 | $ 49,188 | ||
| Fonds de la Recherche en Santé du Québec: Réseau cancerologie | 1996-1999 | $ 181,000 | |
| Abbot Laboratories Inc. | 1999-1999 | $ 25,000 |
(c) 2000 Finestone Laboratory